Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 600812.SS and 80,000+ other tickers.
See exactly how 600812.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 600812.SS and 80,000+ other tickers.
North China Pharmaceutical Company Ltd. is a Chinese firm specializing in the chemical pharmaceutical sector. Its extensive product range primarily features anti-infective medications, supplied as active pharmaceutical ingredients (APIs), their intermediates, and final preparations. The company's offerings further encompass biotechnological therapeutics, drugs for cardiovascular conditions, immunomodulators, vitamin-based consumer health products, and specialized pharmaceuticals for agricultural and veterinary applications. Founded in 1953, North China Pharmaceutical Company Ltd. maintains its headquarters in Shijiazhuang, China.
No recent news available.